Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TSC2: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
TSC2 is a gene implicated in neurodegeneration research. Key relationships include: activates, regulates, interacts with. Associated with Als, Atherosclerosis, Autism. Connected to 180 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | TSC2 |
| Full Name | Tuberous Sclerosis Complex 2 |
| Function | The TSC1-TSC2 heterodimer localizes primarily to the cytoplasm and intracellular membranes, where it senses cellular energy status and growth factor signals. |
| Primary Expression | neurons and regulates synaptic function |
| Subcellular Localization | synapses and regulates dendritic spine morphology and synaptic plasticity |
| Molecular Weight | 200 kDa |
| Amino Acids | 807 aa |
| Pathways | mTOR, mtor, AMPK, PI3K |
| Ensembl ID | ENSG00000103197 |
| GeneCards | TSC2 |
| Human Protein Atlas | TSC2 |
| Inhibition of Rheb | The GAP activity of TSC2 converts active GTP-bound Rheb to inactive GDP-bound Rheb, thereby inhibiting mTORC1 activation<sup>[2]</sup> |
| Energy sensing | TSC2 senses cellular energy (AMP/ATP ratio) through AMPK activation, inhibiting mTORC1 during energy deprivation |
| Growth factor regulation | PI3K/Akt signaling phosphorylates and inhibits TSC2, allowing mTORC1 activation in response to growth factors |
| Cell cycle control | TSC2 loss leads to uncontrolled cell proliferation |
| Associated Diseases | ALS, Diabetes, epilepsy, Ms, neurodegeneration, Parkinson |
| Known Drugs/Compounds | rapamycin |
| Interactions | ACETYL-COA, ACTB, Akt, AKT, AKT1, AKT3 |
| KG Connections | 350 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
TSC2["TSC2"]
TSC2 -->|"inhibits"| mTORC1["mTORC1"]
TSC2 -->|"regulates"| TFEB["TFEB"]
TSC2 -->|"inhibits"| MTORC1["MTORC1"]
TSC2 -->|"binds"| Akt["Akt"]
TSC2 -->|"inhibits"| mTOR["mTOR"]
TSC2 -->|"activates"| Ms["Ms"]
TSC2 -->|"regulates"| Leukemia["Leukemia"]
TSC2 -->|"regulates"| Als["Als"]
TSC2 -->|"regulates"| Autism["Autism"]
TSC2 -->|"activates"| Tumor["Tumor"]
AKT["AKT"] -->|"phosphorylates"| TSC2
TSC1["TSC1"] -->|"interacts"| TSC2
Akt -->|"phosphorylates"| TSC2
alpha_synuclein["alpha-synuclein"] -->|"interacts"| TSC2
mTOR -->|"regulates"| TSC2
EGF["EGF"] -->|"activates"| TSC2
LC3["LC3"] -->|"activates"| TSC2
MTOR["MTOR"] -->|"activates"| TSC2| Target | Relation | Type | Str |
|---|---|---|---|
| mTOR Signaling | inhibits | pathway | 0.95 |
| mTORC1 | inhibits | pathway | 0.90 |
| MTOR | activates | gene | 0.90 |
| Mtor | activates | pathway | 0.90 |
| Mtor | interacts_with | pathway | 0.90 |
| Als | interacts_with | disease | 0.85 |
| TFEB | regulates | gene | 0.85 |
| Akt | binds | protein | 0.80 |
| MTORC1 | inhibits | protein | 0.80 |
| MTORC1 | activates | gene | 0.80 |
| TSC1 | inhibits | gene | 0.80 |
| MTOR | interacts_with | gene | 0.80 |
| Tumor | activates | disease | 0.75 |
| Autism | interacts_with | disease | 0.75 |
| Als | inhibits | disease | 0.75 |
| Cancer | activates | disease | 0.75 |
| Carcinoma | activates | disease | 0.75 |
| MTOR | inhibits | gene | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| MTOR | regulates | gene | 0.70 |
| AUTOPHAGY | activates | gene | 0.70 |
| mTOR | inhibits | protein | 0.70 |
| AKT | activates | gene | 0.70 |
| senescence | participates_in | pathway | 0.70 |
| Mtor | inhibits | pathway | 0.70 |
| autophagy pathway | participates_in | pathway | 0.70 |
| TSC1 | interacts_with | gene | 0.70 |
| GENES | inhibits | gene | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Mtor | regulates | pathway | 0.70 |
| Fatty Liver | activates | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Diabetes | activates | disease | 0.65 |
| Nafld | activates | disease | 0.65 |
| Insulin Resistance | activates | disease | 0.65 |
| Tumor | interacts_with | disease | 0.65 |
| Hepatocellular Carcinoma | activates | disease | 0.65 |
| Atherosclerosis | regulates | disease | 0.65 |
| Epilepsy | interacts_with | disease | 0.65 |
| Cardiac | interacts_with | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Diabetes | associated_with | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| Glioblastoma | activates | disease | 0.65 |
| Parkinson | interacts_with | disease | 0.65 |
| Cancer | regulates | disease | 0.65 |
| Neurodegeneration | inhibits | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| pathologic α-synuclein | binds_to | protein | 0.95 |
| SNCA | binds | protein | 0.90 |
| Akt | inhibits | protein | 0.90 |
| Akt | phosphorylates | protein | 0.90 |
| TSC1 | interacts_with | protein | 0.90 |
| AKT | phosphorylates | protein | 0.90 |
| AKT | inhibits | protein | 0.90 |
| alpha-synuclein | interacts_with | protein | 0.85 |
| RPS6 | activates | gene | 0.70 |
| AKT1 | activates | gene | 0.70 |
| LYSOSOMAL BIOGENESIS | activates | gene | 0.70 |
| SIRT1 | activates | gene | 0.70 |
| mTOR | regulates | pathway | 0.70 |
| SIRT1 | modifies | gene | 0.70 |
| SIRT1 | regulates | gene | 0.70 |
| GLUT4 | activates | gene | 0.65 |
| MTOR | interacts_with | gene | 0.60 |
| HEXB | inhibits | gene | 0.60 |
| TSC1 | activates | gene | 0.60 |
| HDAC6 | biomarker_for | gene | 0.60 |
| MAP1LC3 | activates | gene | 0.60 |
| DMSO | activates | gene | 0.60 |
| AR | activates | gene | 0.60 |
| MAPK8 | biomarker_for | gene | 0.60 |
| TARDBP | associated_with | gene | 0.60 |
| FOXO1 | activates | gene | 0.60 |
| ERN1 | activates | gene | 0.60 |
| PERK | activates | gene | 0.60 |
| HSPA5 | activates | gene | 0.60 |
| INSULIN RESISTANCE | activates | gene | 0.60 |
| EEA1 | activates | gene | 0.60 |
| RNA | interacts_with | gene | 0.60 |
| NEURON | interacts_with | gene | 0.60 |
| EPILEPSY | therapeutic_target | gene | 0.60 |
| PI3K | inhibits | gene | 0.60 |
| AKT3 | activates | gene | 0.60 |
| NPRL2 | activates | gene | 0.60 |
| PIK3CA | activates | gene | 0.60 |
| DEPDC5 | activates | gene | 0.60 |
| NPRL3 | activates | gene | 0.60 |
| NLGN1 | activates | gene | 0.60 |
| NLGN1 | encodes | gene | 0.60 |
| MITOPHAGY | activates | gene | 0.60 |
| MTORC1 | activates | gene | 0.60 |
| IRE1A | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| AUTOPHAGY | inhibits | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | inhibits | gene | 0.60 |
| EPILEPSY | activates | gene | 0.60 |
| MTORC1 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.741
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.763
neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.882
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.90 · 2026-04-06
closed · Rounds: 4 · Score: 0.91 · 2026-04-06
closed · Rounds: 4 · Score: 0.89 · 2026-04-02